The notices it replaced
- Reissues: PAR-23-284 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
- 2 steps back: PAR-20-305 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)
- 3 steps back: PAR-18-313 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
- 4 steps back: PAR-14-353 Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50)
- 5 steps back: PAR-14-031 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50)
- 6 steps back: PAR-12-296 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2013 and 2014 (P50)
- 7 steps back: PAR-10-003 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Years 2010, 2011 and 2012 (P50)
- 8 steps back: PAR-08-020 Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50)
Who won it before
123 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $271,145,514 in first-year total cost, median $2,185,934.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RPRB-7 (M1)]19
- Special Emphasis Panel[ZCA1 RPRB-N (M1)]13
- Special Emphasis Panel[ZCA1 RPRB-8 (M1)]9
- Special Emphasis Panel[ZCA1 RPRB-0 (M1)]8
- Special Emphasis Panel[ZCA1 RPRB-6 (M1)]7
Most frequent institutions
- UNIVERSITY OF TX MD ANDERSON CAN CTR11
- SLOAN-KETTERING INST CAN RESEARCH10
- JOHNS HOPKINS UNIVERSITY8
- DANA-FARBER CANCER INST7
- MAYO CLINIC ROCHESTER7
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer2P50CA168504-11 · under PAR-23-284 | ELLISEN, LEIF WLIN, NANCY UPOLYAK, KORNELIASHAPIRO, GEOFFREY I. | DANA-FARBER CANCER INST, MA | $2,607,297 | ZCA1 |
| 2025 | UT Southwestern Liver Cancer SPORE1P50CA295495-01A1 · under PAR-23-284 | HOSHIDA, YUJINSINGAL, AMIT | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,513,300 | ZCA1 |
| 2025 | Fred Hutchinson Cancer Center Lung SPORE2P50CA228944-07A1 · under PAR-23-284 | HOUGHTON, A MCGARRY | FRED HUTCHINSON CANCER CENTER, WA | $2,471,718 | ZCA1 |
| 2025 | Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer2P50CA236733-06A1 · under PAR-23-284 | COFFEY, ROBERT J. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $2,398,107 | ZCA1 |
| 2025 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer2P50CA196530-11 · under PAR-23-284 | HERBST, ROY SPOLITI, KATERINA ABIGAIL | YALE UNIVERSITY, CT | $2,341,652 | ZCA1 |
| 2025 | Michigan Prostate SPORE 2025-20302P50CA186786-11A1 · under PAR-23-284 | CHINNAIYAN, ARUL MPALAPATTU, GANESH S | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,303,511 | ZCA1 |
| 2025 | Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer1P50CA302572-01 · under PAR-23-284 | HOWE, JAMES RMENDA, YUSUFQUELLE, DAWN E | UNIVERSITY OF IOWA, IA | $2,185,934 | ZCA1 |
| 2025 | MD Anderson Sarcoma SPORE1P50CA302482-01 · under PAR-23-284 | FUTREAL, PHILLIP ANDREWGORLICK, RICHARD G. | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,824,620 | ZCA1 |
| 2024 | Translational Research Program in Cancer Differences across Populations1P50CA285275-01A1 · under PAR-20-305 | LI, CHRISTOPHER IPETERS, ULRIKETHOMAS, TIMOTHY K | FRED HUTCHINSON CANCER CENTER, WA | $2,575,782 | ZCA1 |
| 2024 | Targeted Therapies for Glioma2P50CA165962-11 · under PAR-20-305 | BATCHELOR, TRACY T | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,539,918 | ZCA1 |
| 2024 | SPORE in Ovarian Cancer2P50CA228991-06A1 · under PAR-20-305 | DRAPKIN, RONNY ISHIH, IE-MING | JOHNS HOPKINS UNIVERSITY, MD | $2,496,726 | ZCA1 |
| 2024 | SPORE in Soft Tissue Sarcoma2P50CA217694-06A1 · under PAR-20-305 | SINGER, SAMUEL | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,375,406 | ZCA1 |
| 2024 | SPORE in Breast Cancer2P50CA058223-29A1 · under PAR-20-305 | CAREY, LISA APEROU, CHARLES M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,268,690 | ZCA1 |
| 2024 | Mayo Clinic Hepatobiliary SPORE2P50CA210964-06A1 · under PAR-20-305 | MC NIVEN, MARK A.ROBERTS, LEWIS R | MAYO CLINIC ROCHESTER, MN | $2,236,005 | ZCA1 |
| 2024 | UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer1P50CA275741-01A1 · under PAR-20-305 | FENG, FELIX YI-CHUNGSMALL, ERIC J | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,204,158 | ZCA1 |
| 2024 | SPORE in Prostate Cancer1P50CA272391-01A1 · under PAR-20-305 | DENMEADE, SAMUEL RLUPOLD, SHAWN | JOHNS HOPKINS UNIVERSITY, MD | $2,190,123 | ZCA1 |
| 2024 | Specialized Program of Research Excellence (SPORE) in Leukemia2P50CA171963-11A1 · under PAR-20-305 | LINK, DANIEL C | WASHINGTON UNIVERSITY, MO | $2,109,864 | ZCA1 |
| 2024 | SPORE in Brain Cancer2P50CA127001-16 · under PAR-20-305 | FUEYO, JUANLANG, FREDERICK F | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,088,365 | ZCA1 |
| 2024 | SPORE in Cervical Cancer2P50CA098252-21 · under PAR-20-305 | HUH, WARNER KINGWU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $1,949,494 | ZCA1 |
| 2023 | DF/HCC Prostate SPORE1P50CA272390-01A1 · under PAR-20-305 | BALK, STEVEN P.BELTRAN, HIMISHA | DANA-FARBER CANCER INST, MA | $2,585,567 | ZCA1 |
| 2023 | The Pacific Northwest Prostate Cancer SPORE2P50CA097186-22 · under PAR-20-305 | NELSON, PETER S | FRED HUTCHINSON CANCER CENTER, WA | $2,398,516 | ZCA1 |
| 2023 | Route 66 Endometrial Cancer SPORE1P50CA265793-01A1 · under PAR-20-305 | BENBROOK, DORIS MANGIARACINALESLIE, KIMBERLY K.MUTCH, DAVID G | WASHINGTON UNIVERSITY, MO | $2,384,742 | ZCA1 |
| 2023 | Brain Tumor SPORE Grant2P50CA097257-21 · under PAR-20-305 | BERGER, MITCHEL S. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,316,634 | ZCA1 |
| 2023 | HCC Ovarian Cancer SPORE1P50CA272218-01A1 · under PAR-20-305 | BUCKANOVICH, RONALD JEDWARDS, ROBERT PAGE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,163,827 | ZCA1 |
| 2023 | The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer1P50CA281701-01 · under PAR-20-305 | BAST, ROBERT CSOOD, ANIL K | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,144,148 | ZCA1 |
| 2023 | Molecularly Targeted Radiosensitization of Locally Advanced Cancers1P50CA269022-01A1 · under PAR-20-305 | LAWRENCE, THEODORE SMORGAN, MEREDITH A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,066,150 | ZCA1 |
| 2023 | Washington University SPORE in Pancreatic Cancer1P50CA272213-01A1 · under PAR-20-305 | DENARDO, DAVID GFIELDS, RYAN C | WASHINGTON UNIVERSITY, MO | $2,065,042 | ZCA1 |
| 2023 | University of Wisconsin Prostate SPORE1P50CA269011-01A1 · under PAR-20-305 | JARRARD, DAVID F.MCNEEL, DOUGLAS G. | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,061,062 | ZCA1 |
| 2023 | SPORE for Translational Approaches to Brain Cancer2P50CA221747-06 · under PAR-20-305 | LESNIAK, MACIEJ S | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,044,971 | ZCA1 |
| 2023 | Hawaii Minority Health and Cancer Disparities SPORE1P20CA275734-01A1 · under PAR-20-305 | BERENBERG, JEFFREY LEELE MARCHAND, LOIC | UNIVERSITY OF HAWAII AT MANOA, HI | $1,673,168 | ZCA1 |
| 2023 | Yale SPORE in Skin Cancer2P50CA121974-16 · under PAR-20-305 | BOSENBERG, MARCUS WKLUGER, HARRIET M. | YALE UNIVERSITY, CT | $1,533,274 | ZCA1 |
| 2022 | Dana Farber/Harvard Cancer Center SPORE in Lung Cancer1P50CA265826-01A1 · under PAR-20-305 | BARBIE, DAVID ASEQUIST, LECIA V. | DANA-FARBER CANCER INST, MA | $2,384,337 | ZCA1 |
| 2022 | SPORE in Prostate Cancer2P50CA092629-21A1 · under PAR-20-305 | CHEN, YUSCHER, HOWARD I | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,364,931 | ZCA1 |
| 2022 | The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer1P50CA257881-01A1 · under PAR-20-305 | O'REILLY, EILEEN MARY | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,329,651 | ZCA1 |
| 2022 | Mayo Clinic Breast Cancer SPORE2P50CA116201-16A1 · under PAR-20-305 | GOETZ, MATTHEW PHILIP | MAYO CLINIC ROCHESTER, MN | $2,317,281 | ZCA1 |
| 2022 | Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment1P50CA272170-01 · under PAR-20-305 | SCHUETZE, SCOTT MICHAEL | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,282,833 | ZCA1 |
| 2022 | University of Texas Southwestern Medical Center SPORE in Kidney Cancer2P50CA196516-06A1 · under PAR-20-305 | BRUGAROLAS, JAMESKAPUR, PAYAL | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,173,410 | ZCA1 |
| 2022 | Head and Neck Cancer SPORE2P50CA097190-16A1 · under PAR-20-305 | FERRIS, ROBERT L.SKINNER, HEATH DEVIN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,138,140 | ZCA1 |
| 2022 | Selective Targeting of Pancreatic Cancer SPORE1P50CA257911-01A1 · under PAR-20-305 | YEH, JEN JEN | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,120,012 | ZCA1 |
| 2022 | SPORE in Lymphoma2P50CA126752-16 · under PAR-20-305 | BRENNER, MALCOLM K.HESLOP, HELEN E | BAYLOR COLLEGE OF MEDICINE, TX | $2,062,012 | ZCA1 |
| 2022 | UCLA SPORE in Brain Cancer2P50CA211015-06 · under PAR-20-305 | LIAU, LINDA M | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $2,046,459 | ZCA1 |
| 2022 | Head and Neck Cancer SPORE at the University of Wisconsin2P50CA278595-06A1 · under PAR-20-305 | HARARI, PAUL M | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,028,647 | ZCA1 |
| 2021 | The Memorial Sloan Kettering Cancer Center SPORE in Leukemia1P50CA254838-01 · under PAR-18-313 | ABDEL-WAHAB, OMARTALLMAN, MARTIN S | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,350,964 | ZCA1 |
| 2021 | SPORE in Skin Cancer1P50CA261608-01 · under PAR-18-313 | AMARAVADI, RAVI KHERLYN, MEENHARD F | WISTAR INSTITUTE, PA | $2,323,912 | ZCA1 |
| 2021 | Epigenetic Therapies - New Approaches1P50CA254897-01A1 · under PAR-18-313 | BAYLIN, STEPHEN B.ISSA, JEAN-PIERRE J.JONES, PETER A | CORIELL INSTITUTE FOR MEDICAL RESEARCH, NJ | $2,269,729 | ZCA1 |
| 2021 | Developmental and Hyperactive Ras Tumor (DHART) SPORE2U54CA196519-06A1 · under PAR-18-313 | CLAPP, DAVID WSHANNON, KEVIN M. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $2,198,683 | ZCA1 |
| 2021 | Mayo Clinic Multiple Myeloma SPORE2P50CA186781-06A1 · under PAR-18-313 | BERGSAGEL, PETER LEIF | MAYO CLINIC ARIZONA, AZ | $2,091,215 | ZCA1 |
| 2021 | Melanoma and Skin Cancer Program SPORE1P50CA254865-01A1 · under PAR-18-313 | KIRKWOOD, JOHN MUNNZAROUR, HASSANE M | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,037,632 | ZCA1 |
| 2021 | Colorado Head and Neck Cancer SPORE1P50CA261605-01 · under PAR-18-313 | JIMENO, ANTONIOWANG, XIAO-JING | UNIVERSITY OF COLORADO DENVER, CO | $1,968,453 | ZCA1 |
| 2021 | Mayo Clinic Ovarian Cancer SPORE2P50CA136393-11A1 · under PAR-18-313 | KAUFMANN, SCOTT H | MAYO CLINIC ROCHESTER, MN | $1,762,703 | ZCA1 |
| 2021 | Roswell Park Ovarian Cancer SPORE2P50CA159981-07A1 · under PAR-18-313 | MOYSICH, KIRSTEN B.ODUNSI, KUNLE | ROSWELL PARK CANCER INSTITUTE CORP, NY | $1,716,101 | ZCA1 |
| 2021 | SPORE in Prostate Cancer2P50CA180995-06A1 · under PAR-18-313 | ABDULKADIR, SARKI A.HUSSAIN, MAHA H | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $1,656,783 | ZCA1 |
| 2020 | DF/HCC Kidney Cancer SPORE2P50CA101942-16 · under PAR-18-313 | KAELIN, WILLIAM G.MCDERMOTT, DAVID | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $2,543,224 | ZCA1 |
| 2020 | Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant1P50CA240243-01A1 · under PAR-18-313 | D'ANDREA, ALAN D.MATULONIS, URSULA ANNESPRIGGS, DAVID R | DANA-FARBER CANCER INST, MA | $2,483,069 | ZCA1 |
| 2020 | Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer1P50DE030707-01 · under PAR-18-313 | BURTNESS, BARBARA | YALE UNIVERSITY, CT | $2,354,716 | ZCA1 |
| 2020 | MSK SPORE in Genomic Instability in Breast Cancer1P50CA247749-01 · under PAR-18-313 | POWELL, SIMON N. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,257,697 | ZCA1 |
| 2020 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer2P50CA196530-06 · under PAR-18-313 | HERBST, ROY S | YALE UNIVERSITY, CT | $2,207,890 | ZCA1 |
| 2020 | Targeting Lung Cancer Vulnerabilities2P50CA070907-21A1 · under PAR-18-313 | HEYMACH, JOHN V.MINNA, JOHN D.ROTH, JACK | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,203,273 | ZCA1 |
| 2020 | Translational Research in Breast Cancer2P50CA186784-06 · under PAR-18-313 | ELLIS, MATTHEW J | BAYLOR COLLEGE OF MEDICINE, TX | $2,137,830 | ZCA1 |
| 2019 | Fred Hutchinson Cancer Research Center Lung SPORE1P50CA228944-01A1 · under PAR-18-313 | HOUGHTON, A MCGARRY | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $2,491,191 | ZCA1 |
| 2019 | Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer2P50CA168504-06A1 · under PAR-18-313 | WINER, ERIC P | DANA-FARBER CANCER INST, MA | $2,482,574 | ZCA1 |
| 2019 | Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer2P50CA127003-11A1 · under PAR-18-313 | BASS, ADAM JOELEL-BARDEESY, NABEEL | DANA-FARBER CANCER INST, MA | $2,450,827 | ZCA1 |
| 2019 | SPORE: Targeted Therapies for Glioma2P50CA165962-06A1 · under PAR-18-313 | BATCHELOR, TRACY T | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,438,174 | ZCA1 |
| 2019 | Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer1P50CA236733-01 · under PAR-18-313 | COFFEY, ROBERT J. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $2,368,006 | ZCA1 |
| 2019 | The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma1P50CA217674-01A1 · under PAR-18-313 | BERETTA, LAURAKASEB, AHMED | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,296,647 | ZCA1 |
| 2019 | SPORE in Multiple Myeloma2P50CA100707-16A1 · under PAR-18-313 | ANDERSON, KENNETH C.MUNSHI, NIKHIL C. | DANA-FARBER CANCER INST, MA | $2,276,698 | ZCA1 |
| 2019 | MD Anderson Cancer Center SPORE in Gastrointestinal Cancer1P50CA221707-01A1 · under PAR-18-313 | KOPETZ, SCOTTMAITRA, ANIRBAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,275,719 | ZCA1 |
| 2019 | SPORE in Breast Cancer2P50CA098131-17A1 · under PAR-18-313 | MAYER, INGRID APIETENPOL, JENNIFER A | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $2,218,149 | ZCA1 |
| 2019 | Duke SPORE in Brain Cancer2P50CA190991-06 · under PAR-18-313 | ALI-OSMAN, FRANCISSAMPSON, JOHN H. | DUKE UNIVERSITY, NC | $2,087,874 | ZCA1 |
| 2019 | The University of Texas MD Anderson Cancer Center SPORE in Melanoma1P50CA221703-01A1 · under PAR-18-313 | HWU, PATRICK | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,083,190 | ZCA1 |
| 2019 | SPORE in Brain Cancer2P50CA127001-11A1 · under PAR-18-313 | FUEYO, JUANLANG, FREDERICK F | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,069,263 | ZCA1 |
| 2019 | NYU Melanoma SPORE1P50CA225450-01A1 · under PAR-18-313 | OSMAN, IMANWEBER, JEFFREY S | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $2,063,466 | ZCA1 |
| 2019 | Emory University Lung Cancer SPORE1P50CA217691-01A1 · under PAR-18-313 | FU, HAIANRAMALINGAM, SURESH S | EMORY UNIVERSITY, GA | $1,853,913 | ZCA1 |
| 2019 | Michigan Prostate SPORE2P50CA186786-06 · under PAR-18-313 | CHINNAIYAN, ARUL MHEATH, ELISABETH ILJASPALAPATTU, GANESH S | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $1,783,426 | ZCA1 |
| 2019 | UCLA SPORE in Prostate Cancer2P50CA092131-16A1 · under PAR-18-313 | REITER, ROBERT E | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $1,708,652 | ZCA1 |
| 2019 | SPORE in Cervical Cancer2P50CA098252-16 · under PAR-18-313 | WU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $1,279,343 | ZCA1 |
| 2018 | City of Hope Lymphoma SPORE2P50CA107399-11A1 · under PAR-14-353 | FORMAN, STEPHEN JKWAK, LARRY W | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $2,500,000 | ZCA1 |
| 2018 | Yale SPORE in Skin Cancer2P50CA121974-11A1 · under PAR-14-353 | BOSENBERG, MARCUS WKLUGER, HARRIET M. | YALE UNIVERSITY, CT | $2,500,000 | ZCA1 |
| 2018 | SPORE in Gastrointestinal Cancers2P50CA062924-24A1 · under PAR-14-353 | KLEIN, ALISON P | JOHNS HOPKINS UNIVERSITY, MD | $2,500,000 | ZCA1 |
| 2018 | SPORE in Breast Cancer2P50CA058223-24A1 · under PAR-14-353 | EARP, H. SHELTONPEROU, CHARLES M | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $2,499,932 | ZCA1 |
| 2018 | Brain Tumor SPORE Grant2P50CA097257-16 · under PAR-14-353 | BERGER, MITCHEL S. | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,498,496 | ZCA1 |
| 2018 | SPORE in Ovarian Cancer1P50CA228991-01 · under PAR-14-353 | SHIH, IE-MING | JOHNS HOPKINS UNIVERSITY, MD | $2,492,537 | ZCA1 |
| 2018 | Mayo Clinic Hepatobiliary SPORE1P50CA210964-01A1 · under PAR-14-353 | MC NIVEN, MARK A.ROBERTS, LEWIS R | MAYO CLINIC ROCHESTER, MN | $2,300,000 | ZCA1 |
| 2018 | SPORE for Translational Approaches to Brain Cancer1P50CA221747-01A1 · under PAR-14-353 | LESNIAK, MACIEJ S | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,300,000 | ZCA1 |
| 2018 | Specialized Program Of Research Excellence (SPORE) in Leukemia.2P50CA171963-06 · under PAR-14-353 | LINK, DANIEL C | WASHINGTON UNIVERSITY, MO | $2,299,839 | ZCA1 |
| 2018 | SPORE in Bladder Cancer1P50CA221745-01A1 · under PAR-14-353 | BAJORIN, DEAN F.SOLIT, DAVID B. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,299,837 | ZCA1 |
| 2018 | SPORE in Soft Tissue Sarcoma1P50CA217694-01A1 · under PAR-14-353 | SINGER, SAMUEL | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,286,505 | ZCA1 |
| 2018 | The Pacific Northwest Prostate Cancer SPORE2P50CA097186-16A1 · under PAR-14-353 | NELSON, PETER S | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $2,157,062 | ZCA1 |
| 2018 | SPORE University of Texas M. D. Anderson Cancer Center-Leukemia2P50CA100632-16 · under PAR-14-353 | ISSA, JEAN-PIERRE J.KONOPLEVA, MARINA Y | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,392,864 | ZCA1 |
| 2017 | SPORE in Lymphoma2P50CA126752-11 · under PAR-14-353 | BRENNER, MALCOLM K.HESLOP, HELEN E | BAYLOR COLLEGE OF MEDICINE, TX | $3,097,657 | ZCA1 |
| 2017 | Case GI SPORE2P50CA150964-06A1 · under PAR-14-353 | MARKOWITZ, SANFORD D. | CASE WESTERN RESERVE UNIVERSITY, OH | $2,375,000 | ZCA1 |
| 2017 | Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer2P50CA097274-16 · under PAR-14-353 | WEINER, GEORGE J.WITZIG, THOMAS E. | UNIVERSITY OF IOWA, IA | $2,375,000 | ZCA1 |
| 2017 | SPORE in Myeloid Malignancies1P50CA206963-01A1 · under PAR-14-353 | EBERT, BENJAMIN LEVINESTONE, RICHARD M | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,185,000 | ZCA1 |
| 2017 | UCLA SPORE in Brain Cancer1P50CA211015-01A1 · under PAR-14-353 | LIAU, LINDA M | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $2,185,000 | ZCA1 |
| 2017 | Weill Cornell Medicine (WCM) SPORE in Prostate Cancer1P50CA211024-01A1 · under PAR-14-353 | RUBIN, MARK A. | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $2,184,999 | ZCA1 |
| 2017 | U.T. M. D. Anderson Cancer Center SPORE in Ovarian Cancer1P50CA217685-01 · under PAR-14-353 | BAST, ROBERT CSOOD, ANIL K | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,732,856 | ZCA1 |
| 2016 | Mayo Clinic Breast Cancer SPORE2P50CA116201-11 · under PAR-14-353 | GOETZ, MATTHEW PHILIPINGLE, JAMES NEWELL | MAYO CLINIC ROCHESTER, MN | $2,350,000 | ZCA1 |
| 2016 | SPORE in Prostate Cancer2P50CA092629-16 · under PAR-14-353 | SCHER, HOWARD I | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,349,999 | ZCA1 |
| 2016 | MD Anderson Cancer Center Prostate Cancer SPORE2P50CA140388-06A1 · under PAR-14-353 | LOGOTHETIS, CHRISTOPHER J.THOMPSON, TIMOTHY CHARLES | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,259,759 | ZCA1 |
| 2016 | Washington University SPORE in Pancreatic Cancer1P50CA196510-01A1 · under PAR-14-353 | HAWKINS, WILLIAM G | WASHINGTON UNIVERSITY, MO | $2,186,724 | ZCA1 |
| 2016 | Head and Neck Cancer SPORE at the University of Wisconsin1P50DE026787-01A1 · under PAR-14-353 | HARARI, PAUL M | UNIVERSITY OF WISCONSIN-MADISON, WI | $2,170,679 | ZCA1 |
| 2016 | MSK SPORE in Lymphoma1P50CA192937-01A1 · under PAR-14-353 | YOUNES, ANASZELENETZ, ANDREW D. | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,162,000 | ZCA1 |
| 2016 | The University of Texas Southwestern Medical Center SPORE in Kidney Cancer1P50CA196516-01A1 · under PAR-14-353 | BRUGAROLAS, JAMES | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,162,000 | ZCA1 |
| 2016 | MD Anderson Gynecologic SPORE for Uterine Cancers2P50CA098258-11A1 · under PAR-14-353 | BROADDUS, RUSSELL RLU, KAREN HSIEH | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $2,162,000 | ZCA1 |
| 2015 | Developmental and HyperActive Ras Tumor SPORE1U54CA196519-01 · under PAR-14-031 | CLAPP, DAVID WSHANNON, KEVIN M. | INDIANA UNIVERSITY INDIANAPOLIS, IN | $2,384,507 | ZCA1 |
| 2015 | Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer1P50CA174521-01A1 · under PAR-14-031 | O'DORISIO, M. SUE | UNIVERSITY OF IOWA, IA | $2,185,000 | ZCA1 |
| 2015 | Mayo Clinic Multiple Myeloma SPORE1P50CA186781-01A1 · under PAR-14-031 | BERGSAGEL, PETER LEIF | MAYO CLINIC ARIZONA, AZ | $2,185,000 | ZCA1 |
| 2015 | Head and Neck Cancer SPORE2P50CA097190-11 · under PAR-14-031 | FERRIS, ROBERT L.GRANDIS, JENNIFER RUBIN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $2,185,000 | ZCA1 |
| 2015 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer1P50CA196530-01 · under PAR-14-031 | HERBST, ROY S | YALE UNIVERSITY, CT | $2,185,000 | ZCA1 |
| 2015 | DF/HCC Kidney Cancer SPORE2P50CA101942-11A1 · under PAR-14-031 | KAELIN, WILLIAM G.MCDERMOTT, DAVID | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $2,185,000 | ZCA1 |
| 2015 | SPORE in Prostate Cancer1P50CA180995-01A1 · under PAR-14-031 | CATALONA, WILLIAM J | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $2,185,000 | ZCA1 |
| 2015 | Mayo Clinic Ovarian Cancer SPORE2P50CA136393-06A1 · under PAR-14-031 | KAUFMANN, SCOTT H | MAYO CLINIC ROCHESTER, MN | $2,184,999 | ZCA1 |
| 2014 | SPORE in Skin Cancer1P50CA174523-01A1 · under PAR-12-296 | HERLYN, MEENHARD F | WISTAR INSTITUTE, PA | $2,162,000 | ZCA1 |
| 2014 | SPORE in Lung Cancer2P50CA058187-19A1 · under PAR-12-296 | BUNN, PAUL A. | UNIVERSITY OF COLORADO DENVER, CO | $2,162,000 | ZCA1 |
| 2014 | Translational Research in Breast Cancer (SPORE)1P50CA186784-01 · under PAR-12-296 | OSBORNE, C KENT | BAYLOR COLLEGE OF MEDICINE, TX | $2,162,000 | ZCA1 |
| 2014 | SPORE in Pancreatic Cancer2P50CA127297-06A1 · under PAR-12-296 | HOLLINGSWORTH, MICHAEL A. | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $2,162,000 | ZCA1 |
| 2014 | Mayo Clinic SPORE in Pancreatic Cancer2P50CA102701-11A1 · under PAR-12-296 | PETERSEN, GLORIA M. | MAYO CLINIC ROCHESTER, MN | $2,162,000 | ZCA1 |
| 2014 | SPORE in Prostate Cancer1P50CA186786-01 · under PAR-12-296 | CHINNAIYAN, ARUL M | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $2,162,000 | ZCA1 |
| 2014 | SPORE in Cervical Cancer2P50CA098252-11 · under PAR-12-296 | WU, TZYY-CHOOU | JOHNS HOPKINS UNIVERSITY, MD | $2,162,000 | ZCA1 |
| 2014 | Duke SPORE in Brain Cancer1P50CA190991-01 · under PAR-14-031 | ALI-OSMAN, FRANCISSAMPSON, JOHN H. | DUKE UNIVERSITY, NC | $2,162,000 | ZCA1 |
| 2014 | SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer2P50CA070907-16A1 · under PAR-12-296 | MINNA, JOHN D.ROTH, JACK | UT SOUTHWESTERN MEDICAL CENTER, TX | $2,161,999 | ZCA1 |
| 2014 | SPORE in Thyroid Cancer1P50CA172012-01A1 · under PAR-12-296 | FAGIN, JAMES A | SLOAN-KETTERING INST CAN RESEARCH, NY | $2,008,466 | ZCA1 |
| 2014 | SPORE in Prostate Cancer2P50CA058236-19A1 · under PAR-12-296 | NELSON, WILLIAM GEORGE | JOHNS HOPKINS UNIVERSITY, MD | $1,877,328 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.